Report Highlights
Dermatology Diagnostic Devices and Therapeutics Market: Scope and Methodology
This report on the global dermatology diagnostic devices and therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global dermatology diagnostic devices and therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global dermatology diagnostic devices and therapeutics market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types of diagnostic devices and therapeutics. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of acute skin conditions, chronic skin conditions, skin infections and other dermatology diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Dermatology Diagnostic Devices and Therapeutics Market: Segmentation
Based on product type, the global dermatology diagnostic devices market has been segmented dermatoscopes, microscopes & trichoscopes, and imaging equipment. These segments are further categorized into sub-segments such as contact oil immersion devices, cross-polarized devices and hybrid devices in dermatoscope segment; multispectral confocal microscope, reflectance confocal microscope, Raman spectroscope, and others in dermatology microscopes and trichoscopes segment; and imaging equipment are sub-segmented into x-ray, magnetic resonance imaging, ultrasound, optical coherence tomography, and others.
Based on the drug class, global dermatology therapeutics market is sub-segmented into antibacterial agents, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppressant, and biologics.
Geographically, the global dermatology diagnostic devices and therapeutics market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, China, Japan, India, Australia, Brazil, Egypt, Kuwait, Saudi Arabia, and UAE.
Dermatology Diagnostic Devices and Therapeutics Market: Vendor Analysis
The report also profiles major players in the dermatology diagnostic devices and therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc., LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, Valeant Pharmaceuticals International, Inc., Canfield Scientific, Inc.
Global Dermatology Diagnostic Devices Market, by Product Type
Dermatoscopes
Contact Oil Immersion Dermatoscope
Cross-Polarized Dermatoscopes
Hybrid Dermatoscope
Microscopes and Trichoscopes
Multispectral Photoacaustic Microscopy (PAM)
Reflectance Confocal Microscopy (RCM)
Raman Spectroscopy
Others
Imaging Equipment
X-ray
Magnetic Resonance Imaging (MRI)
Ultrasound
Optical Coherence Tomography (OCT)
Others
Global Dermatology Therapeutics Market, by Drug Class
Antibacterial Agents
Antifungal Agents
Antiviral Agents
Corticosteroids
Retinoids
Immunosuppressants
Biologics
Global Dermatology Diagnostic Devices and Therapeutics Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin America
Middle East & North Africa
Egypt
Kuwait
Saudi Arabia
UAE
Rest of Middle East & North Africa
Rest of the World (RoW)
- Table 1 : Global Dermatology Diagnostic Devices Market, by Product, (US$ Mn), 2014–2024
- Table 2 : Global Dermatoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
- Table 3 : Global Microscopes and Trichoscopes Market Revenue, by Product, (US$ Mn), 2014–2024
- Table 4 : Global Imaging Equipment Market Revenue, by Product, (US$ Mn) , 2014–2024
- Table 5 : Global Dermatology Therapeutics Market, by Drug Class, (US$ Mn), 2014–2024
- Table 6 : Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2024 (US$ Mn)
- Table 7 : Global Dermatology Diagnostic Devices Market Revenue, by Region, (US$ Mn), 2014–2024
- Table 8 : Global Dermatology Therapeutics Market Revenue, by Region, (US$ Mn), 2014–2024
- Table 9 : North America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 10 : North America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
- Table 11 : North America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 12 : North America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 13 : North America Dermatology Imaging Equipment Market Revenue, by Product Type, 2014–2024 (US$ Mn)
- Table 14 : North America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 15 : North America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
- Table 16 : Europe Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 17 : Europe Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
- Table 18 : Europe Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 19 : Europe Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 20 : Europe Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 21 : Europe Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 22 : Europe Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
- Table 23 : APAC Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 24 : Asia Pacific Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
- Table 25 : Asia Pacific Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 26 : Asia Pacific Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 27 : Asia Pacific Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 28 : Asia Pacific Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 29 : Asia Pacific Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
- Table 30 : Latin America Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 31 : Latin America Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
- Table 32 : Latin America Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 33 : Latin America Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 34 : Latin America Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 35 : Latin America Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 36 : Latin America Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
- Table 37 : MENA Dermatology Diagnostic Devices Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 38 : MENA Dermatology Diagnostic Devices Market Revenue, by Device, (US$ Mn), 2014–2024
- Table 39 : MENA Dermatoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 40 : MENA Dermatology Microscopes and Trichoscopes Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 41 : MENA Dermatology Imaging Equipment Market Revenue, by Product Type, (US$ Mn), 2014–2024
- Table 42 : MENA Dermatology Therapeutics Market Revenue, by Country, (US$ Mn), 2014–2024
- Table 43 : MENA Dermatology Therapeutics Market Revenue, by Drug Class, (US$ Mn), 2014–2024
- Figure 1 : Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, by Revenue (US$ Mn), 2014–2024
- Figure 2 : Global Dermatology Diagnostic Devices Market, by Product (US$ Mn), 2015
- Figure 3 : Global Dermatology Therapeutics Market, by Drug Class (US$ Mn), 2015
- Figure 4 : Global Market Share, by Region (Diagnostic Devices) (Value %), 2015 and 2024
- Figure 5 : Global Market Share, by Region (Therapeutics), (Value %), 2015 and 2024
- Figure 6 : Percentage of Population (U.S., China, Japan, and India) over the age of 65: 1980–2050
- Figure 7 : Global Percentage Change in the World’s Population, by Age: 2010–2050
- Figure 8 : Market Share Analysis of Key Players, Dermatology Diagnostic Devices Market (%), 2015
- Figure 9 : Market Share Analysis of Key Players, Dermatology Therapeutics Market (%), 2015
- Figure 10 : Market Attractiveness Analysis, by Device, 2015
- Figure 11 : Market Attractiveness Analysis, by Drug Class, 2015
- Figure 12 : Market Attractiveness Analysis, by Geography, 2015
- Figure 13 : Global Dermatoscopes Market Revenue (US$ Mn), 2014–2024
- Figure 14 : Global Microscopes and Trichoscopes Market Revenue (US$ Mn), 2014–2024
- Figure 15 : Global Imaging Equipment Market Revenue (US$ Mn), 2014–2024
- Figure 16 : Global Antibacterials Market Revenue (US$ Mn), 2014–2024
- Figure 17 : Global Antifungal Agents Market Revenue (US$ Mn), 2014–2024
- Figure 18 : Global Antiviral Agents Market Revenue (US$ Mn), 2014–2024
- Figure 19 : Global Corticosteroids Market Revenue (US$ Mn), 2014–2024
- Figure 20 : Global Retinoids Market Revenue (US$ Mn), 2014–2024
- Figure 21 : Global Immunosuppressants Market Revenue (US$ Mn), 2014–2024
- Figure 22 : Global Biologics Market Revenue (US$ Mn), 2014–2024
- Figure 23 : RoW Dermatology Diagnostic Devices Market Revenue, (US$ Mn), 2014–2024
- Figure 24 : RoW Dermatology Therapeutics Market Revenue, (US$ Mn), 2014–2024
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More